Regional differences in the incidence of self-reported type 2 diabetes in Germany: Results from five population-based studies in Germany (DIAB-CORE Consortium)

Journal of Epidemiology and Community Health

Volumn 68, Issue 11, 2014, Pages 1088-1095

  Schipf, Sabine ^a   Ittermann, Till ^a   Tamayo, Teresa ^b   Holle, Rolf ^c   Schunk, Michaela ^c   Maier, Werner ^c   Meisinger, Christine ^c,d   Thorand, Barbara ^c,d   Kluttig, Alexander ^e   Greiser, Karin Halina ^e,f   Berger, Klaus ^g   Müller, Grit ^g   Moebus, Susanne ^h   Slomiany, Uta ^h   Icks, Andrea ^b   Rathmann, Wolfgang ^b   Völzke, Henry ^a,i  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h UNIVERSITY HOSPITAL ESSEN   (Germany)

ⁱ German Center of Cardiovascular Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE STRUCTURE; COST-BENEFIT ANALYSIS; DIABETES; DISEASE INCIDENCE; HEALTH CARE; LONG-TERM CHANGE; PARTICIPATORY APPROACH; REGIONALIZATION;

GERMANY;

AGE DISTRIBUTION; AGED; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GEOGRAPHY; GERMANY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; POISSON DISTRIBUTION; SELF REPORT; SEX RATIO;

AGE DISTRIBUTION; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GEOGRAPHY; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POISSON DISTRIBUTION; SELF REPORT; SEX DISTRIBUTION;

EID: 84911405091     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2014-203998     Document Type: Article

References (34)

1. Wilke T, Ahrendt P, Schwartz D, et al. [Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients]. Dtsch Med Wochenschr 2013;138:69-75.
2. Rathmann W, Strassburger K, Heier M, et al. Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 2009;26:1212-19.
3. Schipf S, Werner A, Tamayo T, et al. Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med 2012;29:e88-95.
4. Barker LE, Kirtland KA, Gregg EW, et al. Geographic distribution of diagnosed diabetes in the US: a diabetes belt. Am J Prev Med 2011;40:434-9.
5. Stang A, Döring A, Völzke H, et al. Regional differences in body fat distributions among people with comparable body mass index: a comparison across six German population-based surveys. Eur J Cardiovasc Prev Rehabil 2010;18:106-14.
6. Meisinger C, Heier M, Völzke H, et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens 2006;24:293-9.
7. Hauner H, Bramlage P, Losch C, et al. Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care. Dtsch Arztebl Int 2008;105:827-33.
8. Robert-Koch-Institut. Beiträge zur Gesundheitsberichterstattung. 20 Jahre nach dem Fall der Mauer: Wie hat sich die Gesundheit in Deutschland entwickelt? 2009:1-302.
9. Liese AD, Lawson A, Song HR, et al. Evaluating geographic variation in type 1 and type 2 diabetes mellitus incidence in youth in four US regions. Health Place 2010;16:547-56.
10. Liu M, Wang Z, Sun X, et al. Rapid increase in the incidence of clinically diagnosed type 2 diabetes in Chinese in Harbin between 1999 and 2005. Prim Care Diabetes 2007;1:123-8.
11. Greiser KH, Kluttig A, Schumann B, et al. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord 2005;5:33.
12. Khil L, Pfaffenrath V, Straube A, et al. Incidence of migraine and tension-type headache in three different populations at risk within the German DMKG headache study. Cephalalgia 2011;32:328-36.
13. Erbel R, Mohlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz-Nixdorf Recall study. J Am Coll Cardiol 2010;56:1397-406.
14. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003;46:182-9.
15. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2010;39:1-14.
16. Kawachi I, Kennedy BP. The relationship of income inequality to mortality: does the choice of indicator matter? Soc Sci Med 1997;45:1121-7.
17. GBE-Gesundheitsberichterstattung des Bundes. Deutsche Bevölkerung am Jahresende, 31.12.2007. 2010. http://www.gbe-bund.de.
18. Hogan JW, Roy J, Korkontzelou C. Handling drop-out in longitudinal studies. Stat Med 2004;23:1455-97.
19. Forouhi NG, Luan J, Hennings S, et al. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 2007;24:200-7.
20. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29.
21. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007;369:750-6.
22. Mensink G, Schienkiewitz A, Scheidt-Nave C. DEGS-Symposium Robert Koch-Institut Berlin. 2012. http://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/Degs/ degs_w1/Symposium/degs_uebergewicht_adipositas.pdf.
23. Maier W, Holle R, Hunger M, et al. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med 2012;30:e78-86.
24. Ayyagari P, Grossman D, Sloan F. Education and health: evidence on adults with diabetes. Int J Health Care Finance Econ 2011;11:35-54.
25. Maier W, Scheidt-Nave C, Holle R, et al. Area level deprivation is an independent determinant of prevalent type 2 diabetes and obesity at the national level in Germany. Results from the National Telephone Health Interview Surveys 'German Health Update' GEDA 2009 and 2010. PLoS ONE 2014;9:e89661.
26. Moebus S, Hanisch JU, Aidelsburger P, et al. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2007;6:22.
27. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007;4(Suppl B):S162-77.
28. Schipf S, Alte D, Völzke H, et al. Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP). Diabetes Stoffwechse 2010;5:161-8.
29. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002;162:1737-45.
30. Natarajan S, Liao Y, Cao G, et al. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003;163:1735-40.
31. Meisinger C, Strassburger K, Heier M, et al. Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study. Diabet Med 2010;27:360-2.
32. Schneider AL, Pankow JS, Heiss G, et al. Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiol 2012;176:738-43.
33. BARMER GEK (Hrsg). Barmer GEK Arztreport. Schriftenreihe zur Gesundheitsanalyse, Band 8. St. Augustin, 2013.
34. Kerner W, Brückel J. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetes Stoffwechse 2011;6:S107-S10.